# Turning the groundwork into a top-tier paper

## The core problem to avoid: toolkit sprawl
We have built a lot (5 instruments, taxonomy, calibration, triangulation, 10 trials). A top-tier paper makes
ONE memorable claim, not an inventory. The winning move is to lead with a single crisp narrative and demote
everything else to supplement.

## The ONE winning narrative (methods + clinical, benchmark-anchored)
> "Reflexive, lab-triggered inpatient treatments are given millions of times a year on little/no trial
> evidence, and observational studies cannot settle them because treatment is a near-deterministic function of
> the severity that also drives outcomes (confounding by indication). We introduce a causal method that exploits
> **assay noise at the decision threshold** as a natural randomizer. We show — across a **library of landmark
> RCTs** (transfusion, glucose control, platelet, bicarbonate, antipsychotic) — that the method **recovers the
> trial answer from EHR data whose naive analysis shows spurious harm**, then apply it to the largest
> unanswered de-implementation question (**reflexive electrolyte repletion**)."

This is the RCT-benchmarked-emulation frame (Franklin/Schneeweiss "RCT-DUPLICATE"), which is the credibility
paradigm top journals now accept for observational causal claims. It converts "trust my weak IV" into "watch it
reproduce trials you already believe."

## The killer figure (the paper IS this figure)
**Calibration plot:** x-axis = RCT truth (effect size) for each benchmark case; y-axis = the method's estimate.
Points on the diagonal = the method recovers truth. Overlay the **naive** estimates as a second series falling
OFF the diagonal (systematic false harm). One figure shows: naive is confounded, the method is calibrated.
Companion: a forest plot, per case, of naive vs method vs RCT 95% CI.

## Structure (clinical top-tier, e.g. JAMA / JAMA IM / Annals)
1. Intro: scale + evidence vacuum of reflexive lab-triggered care; why observational studies fail here.
2. Methods: the assay-noise instrument (one paragraph of intuition + the identification), the falsification
   battery, negative-control calibration, pre-registration.
3. **Validation (the spine):** the RCT-benchmark library — method recovers each trial; naive fails.
4. **Application:** the vacuum question(s) — electrolyte repletion (+ K, bicarb) — with the full battery.
5. Discussion: what it means for practice + the generalizable method.
Pure-methods depth (renewal derivation, contraindication-gate, nurse-PRN, attending-RDD) → a SECOND paper in a
stats/methods venue (JASA/Biometrics/AJE), cross-cited.

## What ELEVATES it from "good" to top-tier (the two additions that matter)
1. **External replication in a SECOND database.** Top-tier demands it. Re-run the benchmark + application in
   **eICU** (already accessible) — same method, different hospitals, same recovery of RCT truth = decisive.
   Optionally a third (a Clarity/OMOP source). This single addition is the biggest lift in perceived rigor.
2. **A definitive, practice-relevant CLINICAL answer**, not just a method demo. The electrolyte-repletion result
   must be precise enough (the flag-ITT is well-powered) to change a guideline — pair it with the RESTRAINT RCT
   protocol as the confirmatory next step ("here is the answer, and here is the trial to confirm it").

## Honest gaps to close before submission (in priority order)
1. Real-data benchmark table (naive vs method vs RCT) — pending download; engines already emit it.
2. External replication (eICU) — re-point the same engines at eICU streams.
3. ≥5 benchmark cases with clean RCT truths, pre-registered thresholds (avoid cherry-picking).
4. Negative-control calibration reported on EVERY estimate (built; must be shown, not just available).
5. Sensitivity/robustness surface (bandwidth × control × outcome) + competing-risks outcomes.
6. Precise novelty statement vs Eckles 2025 / Bosch 2022 (formal noise model + renewal + gate/PRN/rotation +
   the trigger-matching framework + the balance-insufficient/NC-mandatory result).

## Sequencing (fastest credible path)
- **Paper A (lead, clinical top-tier):** benchmark-validated method + electrolyte de-implementation answer,
  replicated in eICU. This is the flagship. Needs: real data + eICU replication.
- **Paper B (methods):** assay-noise IV formalization + renewal + the new instruments. Needs: real Mg/Hb battery.
- **Paper C (trial):** RESTRAINT pragmatic cluster-RCT protocol (already drafted) as the registered confirmatory.
- The clinical portfolio trials that pass become rapid follow-on letters/papers.

## The one-sentence pitch to a top-tier editor
"An observational causal method that reproduces the results of five landmark ICU trials from routine EHR data —
where the naive analysis shows the opposite — and then answers a high-volume treatment question no trial has,
replicated across two hospital systems."
